dpp-4 inhibitor and glp-1 receptor agonist combination not recommended guideline Molecular Insights into the Potential Cardiometabolic Effects of Analogs Inhibitors Insights into the Roles of

This study investigates the effects of allulose, a rare sugar shown to reduce blood glucose, in a rat model of diet-induced obesity and T2D

Ozempic, Wegovy, Zepbound, and Mounjaro are GLP-1 medications that help lower blood sugar

A-RDN induced significant increases in diuretic and natriuretic responses to GLP-1 in HF (urine flow 96.01.9 vs

Glucagon-like peptide-1 (GLP-1) is one of the incretins that regulate glucose metabolism

Obesity is a complex disease characterized by excessive fat accumulation which is caused by genetic, environmental and other factors

While GLP-1 RAs induce weight loss in diabetes, their metabolic impact in normoglycaemic PD patients appears limited